Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling.
Su Z, Han S, Jin Q, Zhou N, Lu J, Shangguan F, Yu S, Liu Y, Wang L, Lu J, Li Q, Cai L, Wang C, Tian X, Chen L, Zheng W, Lu B.
Su Z, et al. Among authors: lu j, lu b.
Cell Death Dis. 2021 Mar 5;12(3):251. doi: 10.1038/s41419-021-03535-9.
Cell Death Dis. 2021.
PMID: 33674562
Free PMC article.